Nicola Leske Named DHL’s EVP of Group Communications & Sustainability
The executive joins the logistics provider with over two decades of relevant experience.
Nicola Leske has assumed the role as EVP, group communications & sustainability, at DHL Group. In this position. she will report to Tobias Meyer, the company’s CEO.
Leske brings more than 20 years of experience in all aspects of communications, and, prior to joining DHL Group, was most recently managing partner at the strategic communications consultancy Gauly Advisors, where she advised international and German companies on all aspects of corporate communications.
Previously, Leske was chief communications officer responsible for overall communications at the international software group SAP SE. In this role, her responsibilities included the strategic positioning of the company and the executive board, as well as corporate social responsibility. Before joining SAP in 2014, the long-time business journalist worked for the Thomson Reuters news agency in various departments and locations, including Frankfurt/M., Amsterdam, and New York.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
